Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Alibaba Health Information Technology (241N) AI Stock Analysis

MX:241N

Alibaba Health Information Technology

(BMV:241N)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Conservative Balance SheetExtremely low leverage gives Alibaba Health substantial financial resilience and reduces interest and refinancing pressure. Growing equity alongside earnings provides a stronger capital base, preserving flexibility to invest in healthcare platforms, products, and services through changing conditions.
Negative Factors
Decelerating Revenue GrowthRecent top-line growth has slowed sharply after the company’s earlier expansion, which may limit operating leverage and reduce the pace at which earnings can compound. Continued deceleration would make it harder to absorb fixed platform costs and sustain improving profitability.

Alibaba Health Information Technology (241N) vs. SPDR S&P 500 ETF (SPY)

-10%-5%0%5%10%15%20%MX:241N0.00%SPY+11.79%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Market Cap
MXN 5.27B
Dividend Yield
―
Average Volume (3M)
―
Price to Earnings (P/E)
20.1
Beta (1Y)
0.00
Revenue Growth
9.36%
EPS Growth
33.38%
Country
Mexico
Employees
1,394
Sector
Healthcare
Sector Strength
51
Industry
Medical - Healthcare Information Services

Alibaba Health Information Technology Business Overview & Revenue Model

Company Description

Alibaba Health Information Technology Limited, an investment holding company, engages in the pharmaceutical direct sales, pharmaceutical e-commerce platform, and healthcare and digital services businesses in Mainland China and Hong Kong. The company...

Alibaba Health Information Technology Peers Comparison

Overall Rating

Financial Indicators

MX:241N against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%

* Healthcare Sector Average

Performance Comparison

0%0%0%0%0%0%MX:241NDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
MX:241N and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
MX:241NAlibaba Health Information Technology 58.930.000.00%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.